nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—breast cancer	0.545	1	CbGaD
Carbachol—PLA2G4A—Epirubicin—breast cancer	0.199	1	CbGbCtD
Carbachol—CHRM3—muscle of abdomen—breast cancer	0.00633	0.265	CbGeAlD
Carbachol—CHRNA2—mammary gland—breast cancer	0.00279	0.117	CbGeAlD
Carbachol—PLA2G4A—Estradiol—Fulvestrant—breast cancer	0.00192	0.531	CbGdCrCtD
Carbachol—PLA2G4A—nipple—breast cancer	0.00187	0.078	CbGeAlD
Carbachol—Choline—PDE4D—breast cancer	0.00131	0.339	CrCbGaD
Carbachol—PLA2G4A—Raltitrexed—Methotrexate—breast cancer	0.00115	0.318	CbGdCrCtD
Carbachol—PLA2G4A—endometrium—breast cancer	0.00113	0.0471	CbGeAlD
Carbachol—PLA2G4A—pituitary gland—breast cancer	0.00102	0.0426	CbGeAlD
Carbachol—Choline—ACHE—breast cancer	0.00102	0.263	CrCbGaD
Carbachol—PLA2G4A—adipose tissue—breast cancer	0.00102	0.0424	CbGeAlD
Carbachol—CHRNA2—endocrine gland—breast cancer	0.000976	0.0408	CbGeAlD
Carbachol—Succinylcholine—BCHE—breast cancer	0.000942	0.243	CrCbGaD
Carbachol—PLA2G4A—female reproductive system—breast cancer	0.000933	0.039	CbGeAlD
Carbachol—PLA2G4A—adrenal gland—breast cancer	0.000911	0.0381	CbGeAlD
Carbachol—PLA2G4A—bone marrow—breast cancer	0.000881	0.0368	CbGeAlD
Carbachol—PLA2G4A—female gonad—breast cancer	0.000849	0.0355	CbGeAlD
Carbachol—PLA2G4A—endocrine gland—breast cancer	0.00079	0.033	CbGeAlD
Carbachol—CHRM1—female reproductive system—breast cancer	0.000626	0.0262	CbGeAlD
Carbachol—CHRM3—adipose tissue—breast cancer	0.000609	0.0255	CbGeAlD
Carbachol—Choline—BCHE—breast cancer	0.000599	0.155	CrCbGaD
Carbachol—CHRM2—endocrine gland—breast cancer	0.000582	0.0243	CbGeAlD
Carbachol—CHRM3—female reproductive system—breast cancer	0.00056	0.0234	CbGeAlD
Carbachol—PLA2G4A—lymph node—breast cancer	0.000546	0.0228	CbGeAlD
Carbachol—CHRM1—endocrine gland—breast cancer	0.00053	0.0221	CbGeAlD
Carbachol—CHRM3—female gonad—breast cancer	0.00051	0.0213	CbGeAlD
Carbachol—CHRM3—endocrine gland—breast cancer	0.000474	0.0198	CbGeAlD
Carbachol—PLA2G4A—Betamethasone—Fluoxymesterone—breast cancer	0.000274	0.0758	CbGdCrCtD
Carbachol—PLA2G4A—Dexamethasone—Fluoxymesterone—breast cancer	0.000274	0.0758	CbGdCrCtD
Carbachol—Arrhythmia—Fluorouracil—breast cancer	0.0002	0.00135	CcSEcCtD
Carbachol—Dyspepsia—Goserelin—breast cancer	0.000198	0.00133	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—breast cancer	0.000197	0.00133	CcSEcCtD
Carbachol—Pain—Melphalan—breast cancer	0.000197	0.00133	CcSEcCtD
Carbachol—Muscle spasms—Irinotecan—breast cancer	0.000195	0.00132	CcSEcCtD
Carbachol—Asthma—Capecitabine—breast cancer	0.000195	0.00132	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—breast cancer	0.000195	0.00131	CcSEcCtD
Carbachol—Nausea—Raloxifene—breast cancer	0.000194	0.00131	CcSEcCtD
Carbachol—Nausea—Idarubicin—breast cancer	0.000194	0.00131	CcSEcCtD
Carbachol—Pain—Goserelin—breast cancer	0.000192	0.0013	CcSEcCtD
Carbachol—Abdominal pain—Vinblastine—breast cancer	0.000191	0.00129	CcSEcCtD
Carbachol—Infection—Thiotepa—breast cancer	0.000191	0.00129	CcSEcCtD
Carbachol—Sweating increased—Capecitabine—breast cancer	0.00019	0.00128	CcSEcCtD
Carbachol—Hypotension—Vinorelbine—breast cancer	0.000188	0.00127	CcSEcCtD
Carbachol—Abdominal discomfort—Capecitabine—breast cancer	0.000187	0.00126	CcSEcCtD
Carbachol—Abdominal pain—Tamoxifen—breast cancer	0.000186	0.00125	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—breast cancer	0.000183	0.00123	CcSEcCtD
Carbachol—Syncope—Irinotecan—breast cancer	0.000182	0.00123	CcSEcCtD
Carbachol—Diarrhoea—Chlorambucil—breast cancer	0.000181	0.00122	CcSEcCtD
Carbachol—Loss of consciousness—Irinotecan—breast cancer	0.000179	0.0012	CcSEcCtD
Carbachol—Abdominal pain—Goserelin—breast cancer	0.000178	0.0012	CcSEcCtD
Carbachol—Body temperature increased—Goserelin—breast cancer	0.000178	0.0012	CcSEcCtD
Carbachol—Flushing—Paclitaxel—breast cancer	0.000177	0.00119	CcSEcCtD
Carbachol—Pain—Vinorelbine—breast cancer	0.000172	0.00116	CcSEcCtD
Carbachol—Arrhythmia—Paclitaxel—breast cancer	0.00017	0.00115	CcSEcCtD
Carbachol—Dyspepsia—Thiotepa—breast cancer	0.000169	0.00114	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—breast cancer	0.000169	0.00114	CcSEcCtD
Carbachol—Vomiting—Chlorambucil—breast cancer	0.000168	0.00113	CcSEcCtD
Carbachol—Diarrhoea—Vinblastine—breast cancer	0.000166	0.00112	CcSEcCtD
Carbachol—Infection—Irinotecan—breast cancer	0.000165	0.00111	CcSEcCtD
Carbachol—Infection—Mitoxantrone—breast cancer	0.000165	0.00111	CcSEcCtD
Carbachol—Pain—Thiotepa—breast cancer	0.000164	0.00111	CcSEcCtD
Carbachol—Flatulence—Paclitaxel—breast cancer	0.000163	0.0011	CcSEcCtD
Carbachol—Shock—Mitoxantrone—breast cancer	0.000163	0.0011	CcSEcCtD
Carbachol—Shock—Irinotecan—breast cancer	0.000163	0.0011	CcSEcCtD
Carbachol—Diarrhoea—Tamoxifen—breast cancer	0.000161	0.00109	CcSEcCtD
Carbachol—Infection—Gemcitabine—breast cancer	0.000161	0.00108	CcSEcCtD
Carbachol—Hyperhidrosis—Irinotecan—breast cancer	0.00016	0.00108	CcSEcCtD
Carbachol—Hyperhidrosis—Mitoxantrone—breast cancer	0.00016	0.00108	CcSEcCtD
Carbachol—Dizziness—Vinblastine—breast cancer	0.00016	0.00108	CcSEcCtD
Carbachol—Muscle spasms—Paclitaxel—breast cancer	0.000159	0.00107	CcSEcCtD
Carbachol—Body temperature increased—Vinorelbine—breast cancer	0.000159	0.00107	CcSEcCtD
Carbachol—Abdominal pain—Vinorelbine—breast cancer	0.000159	0.00107	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—breast cancer	0.000158	0.00107	CcSEcCtD
Carbachol—Infection—Fluorouracil—breast cancer	0.000158	0.00106	CcSEcCtD
Carbachol—Diarrhoea—Melphalan—breast cancer	0.000158	0.00106	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—breast cancer	0.000157	0.00106	CcSEcCtD
Carbachol—Nausea—Chlorambucil—breast cancer	0.000157	0.00106	CcSEcCtD
Carbachol—Hyperhidrosis—Gemcitabine—breast cancer	0.000156	0.00105	CcSEcCtD
Carbachol—Dizziness—Tamoxifen—breast cancer	0.000156	0.00105	CcSEcCtD
Carbachol—Hypotension—Mitoxantrone—breast cancer	0.000155	0.00105	CcSEcCtD
Carbachol—Hypotension—Irinotecan—breast cancer	0.000155	0.00105	CcSEcCtD
Carbachol—Vomiting—Vinblastine—breast cancer	0.000154	0.00104	CcSEcCtD
Carbachol—Diarrhoea—Goserelin—breast cancer	0.000154	0.00104	CcSEcCtD
Carbachol—Abdominal pain—Thiotepa—breast cancer	0.000152	0.00102	CcSEcCtD
Carbachol—Body temperature increased—Thiotepa—breast cancer	0.000152	0.00102	CcSEcCtD
Carbachol—Headache—Vinblastine—breast cancer	0.000152	0.00102	CcSEcCtD
Carbachol—Hypotension—Gemcitabine—breast cancer	0.000151	0.00102	CcSEcCtD
Carbachol—Flushing—Docetaxel—breast cancer	0.00015	0.00101	CcSEcCtD
Carbachol—Vomiting—Tamoxifen—breast cancer	0.00015	0.00101	CcSEcCtD
Carbachol—Syncope—Paclitaxel—breast cancer	0.000149	0.001	CcSEcCtD
Carbachol—Dizziness—Goserelin—breast cancer	0.000149	0.001	CcSEcCtD
Carbachol—Hypotension—Fluorouracil—breast cancer	0.000148	0.001	CcSEcCtD
Carbachol—Rash—Tamoxifen—breast cancer	0.000148	0.001	CcSEcCtD
Carbachol—Dermatitis—Tamoxifen—breast cancer	0.000148	0.000999	CcSEcCtD
Carbachol—Headache—Tamoxifen—breast cancer	0.000147	0.000994	CcSEcCtD
Carbachol—Vomiting—Melphalan—breast cancer	0.000146	0.000987	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—breast cancer	0.000146	0.000986	CcSEcCtD
Carbachol—Dyspepsia—Mitoxantrone—breast cancer	0.000146	0.000985	CcSEcCtD
Carbachol—Dyspepsia—Irinotecan—breast cancer	0.000146	0.000985	CcSEcCtD
Carbachol—Loss of consciousness—Paclitaxel—breast cancer	0.000146	0.000983	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000146	0.000982	CcSEcCtD
Carbachol—Asthma—Methotrexate—breast cancer	0.000145	0.00098	CcSEcCtD
Carbachol—Rash—Melphalan—breast cancer	0.000145	0.000979	CcSEcCtD
Carbachol—Flushing—Capecitabine—breast cancer	0.000145	0.000978	CcSEcCtD
Carbachol—Dermatitis—Melphalan—breast cancer	0.000145	0.000978	CcSEcCtD
Carbachol—Arrhythmia—Docetaxel—breast cancer	0.000144	0.000973	CcSEcCtD
Carbachol—Nausea—Vinblastine—breast cancer	0.000144	0.00097	CcSEcCtD
Carbachol—Vomiting—Goserelin—breast cancer	0.000143	0.000963	CcSEcCtD
Carbachol—Pain—Mitoxantrone—breast cancer	0.000142	0.000957	CcSEcCtD
Carbachol—Pain—Irinotecan—breast cancer	0.000142	0.000957	CcSEcCtD
Carbachol—Rash—Goserelin—breast cancer	0.000142	0.000955	CcSEcCtD
Carbachol—Dermatitis—Goserelin—breast cancer	0.000142	0.000954	CcSEcCtD
Carbachol—Headache—Goserelin—breast cancer	0.000141	0.000949	CcSEcCtD
Carbachol—Dyspepsia—Fluorouracil—breast cancer	0.00014	0.000943	CcSEcCtD
Carbachol—Nausea—Tamoxifen—breast cancer	0.00014	0.000942	CcSEcCtD
Carbachol—Arrhythmia—Capecitabine—breast cancer	0.00014	0.000942	CcSEcCtD
Carbachol—Abdominal discomfort—Methotrexate—breast cancer	0.000139	0.00094	CcSEcCtD
Carbachol—Pain—Gemcitabine—breast cancer	0.000138	0.000932	CcSEcCtD
Carbachol—Diarrhoea—Vinorelbine—breast cancer	0.000138	0.000928	CcSEcCtD
Carbachol—Nausea—Melphalan—breast cancer	0.000137	0.000922	CcSEcCtD
Carbachol—Asthma—Epirubicin—breast cancer	0.000136	0.000917	CcSEcCtD
Carbachol—Pain—Fluorouracil—breast cancer	0.000136	0.000916	CcSEcCtD
Carbachol—Muscle spasms—Docetaxel—breast cancer	0.000135	0.000911	CcSEcCtD
Carbachol—Infection—Paclitaxel—breast cancer	0.000134	0.000907	CcSEcCtD
Carbachol—Flatulence—Capecitabine—breast cancer	0.000134	0.000904	CcSEcCtD
Carbachol—Nausea—Goserelin—breast cancer	0.000133	0.0009	CcSEcCtD
Carbachol—Shock—Paclitaxel—breast cancer	0.000133	0.000898	CcSEcCtD
Carbachol—Dizziness—Vinorelbine—breast cancer	0.000133	0.000897	CcSEcCtD
Carbachol—Diarrhoea—Thiotepa—breast cancer	0.000131	0.000887	CcSEcCtD
Carbachol—Body temperature increased—Irinotecan—breast cancer	0.000131	0.000885	CcSEcCtD
Carbachol—Abdominal pain—Mitoxantrone—breast cancer	0.000131	0.000885	CcSEcCtD
Carbachol—Abdominal pain—Irinotecan—breast cancer	0.000131	0.000885	CcSEcCtD
Carbachol—Body temperature increased—Mitoxantrone—breast cancer	0.000131	0.000885	CcSEcCtD
Carbachol—Muscle spasms—Capecitabine—breast cancer	0.000131	0.000882	CcSEcCtD
Carbachol—Hyperhidrosis—Paclitaxel—breast cancer	0.000131	0.000882	CcSEcCtD
Carbachol—Vomiting—Vinorelbine—breast cancer	0.000128	0.000863	CcSEcCtD
Carbachol—Body temperature increased—Gemcitabine—breast cancer	0.000128	0.000862	CcSEcCtD
Carbachol—Dizziness—Thiotepa—breast cancer	0.000127	0.000857	CcSEcCtD
Carbachol—Rash—Vinorelbine—breast cancer	0.000127	0.000855	CcSEcCtD
Carbachol—Dermatitis—Vinorelbine—breast cancer	0.000127	0.000855	CcSEcCtD
Carbachol—Hypotension—Paclitaxel—breast cancer	0.000126	0.000853	CcSEcCtD
Carbachol—Headache—Vinorelbine—breast cancer	0.000126	0.00085	CcSEcCtD
Carbachol—Syncope—Docetaxel—breast cancer	0.000126	0.00085	CcSEcCtD
Carbachol—Asthma—Doxorubicin—breast cancer	0.000126	0.000849	CcSEcCtD
Carbachol—Body temperature increased—Fluorouracil—breast cancer	0.000126	0.000847	CcSEcCtD
Carbachol—Sweating—Methotrexate—breast cancer	0.000124	0.000838	CcSEcCtD
Carbachol—Loss of consciousness—Docetaxel—breast cancer	0.000124	0.000833	CcSEcCtD
Carbachol—Vomiting—Thiotepa—breast cancer	0.000122	0.000824	CcSEcCtD
Carbachol—Syncope—Capecitabine—breast cancer	0.000122	0.000823	CcSEcCtD
Carbachol—Rash—Thiotepa—breast cancer	0.000121	0.000817	CcSEcCtD
Carbachol—Dermatitis—Thiotepa—breast cancer	0.000121	0.000816	CcSEcCtD
Carbachol—Headache—Thiotepa—breast cancer	0.00012	0.000812	CcSEcCtD
Carbachol—Loss of consciousness—Capecitabine—breast cancer	0.00012	0.000806	CcSEcCtD
Carbachol—Nausea—Vinorelbine—breast cancer	0.00012	0.000806	CcSEcCtD
Carbachol—Dyspepsia—Paclitaxel—breast cancer	0.000119	0.000803	CcSEcCtD
Carbachol—Sweating—Epirubicin—breast cancer	0.000116	0.000784	CcSEcCtD
Carbachol—Pain—Paclitaxel—breast cancer	0.000116	0.00078	CcSEcCtD
Carbachol—Nausea—Thiotepa—breast cancer	0.000114	0.00077	CcSEcCtD
Carbachol—Infection—Docetaxel—breast cancer	0.000114	0.000768	CcSEcCtD
Carbachol—Diarrhoea—Mitoxantrone—breast cancer	0.000114	0.000766	CcSEcCtD
Carbachol—Diarrhoea—Irinotecan—breast cancer	0.000114	0.000766	CcSEcCtD
Carbachol—Shock—Docetaxel—breast cancer	0.000113	0.000761	CcSEcCtD
Carbachol—Diarrhoea—Gemcitabine—breast cancer	0.000111	0.000746	CcSEcCtD
Carbachol—Infection—Capecitabine—breast cancer	0.00011	0.000744	CcSEcCtD
Carbachol—Dizziness—Irinotecan—breast cancer	0.00011	0.00074	CcSEcCtD
Carbachol—Shock—Capecitabine—breast cancer	0.000109	0.000737	CcSEcCtD
Carbachol—Diarrhoea—Fluorouracil—breast cancer	0.000109	0.000733	CcSEcCtD
Carbachol—Sweating—Doxorubicin—breast cancer	0.000108	0.000726	CcSEcCtD
Carbachol—Hyperhidrosis—Capecitabine—breast cancer	0.000107	0.000724	CcSEcCtD
Carbachol—Hypotension—Docetaxel—breast cancer	0.000107	0.000723	CcSEcCtD
Carbachol—Body temperature increased—Paclitaxel—breast cancer	0.000107	0.000721	CcSEcCtD
Carbachol—Abdominal pain—Paclitaxel—breast cancer	0.000107	0.000721	CcSEcCtD
Carbachol—Vomiting—Mitoxantrone—breast cancer	0.000105	0.000711	CcSEcCtD
Carbachol—Vomiting—Irinotecan—breast cancer	0.000105	0.000711	CcSEcCtD
Carbachol—Dizziness—Fluorouracil—breast cancer	0.000105	0.000709	CcSEcCtD
Carbachol—Rash—Mitoxantrone—breast cancer	0.000105	0.000705	CcSEcCtD
Carbachol—Rash—Irinotecan—breast cancer	0.000105	0.000705	CcSEcCtD
Carbachol—Dermatitis—Mitoxantrone—breast cancer	0.000105	0.000705	CcSEcCtD
Carbachol—Dermatitis—Irinotecan—breast cancer	0.000105	0.000705	CcSEcCtD
Carbachol—Headache—Mitoxantrone—breast cancer	0.000104	0.000701	CcSEcCtD
Carbachol—Headache—Irinotecan—breast cancer	0.000104	0.000701	CcSEcCtD
Carbachol—Hypotension—Capecitabine—breast cancer	0.000104	0.0007	CcSEcCtD
Carbachol—Vomiting—Gemcitabine—breast cancer	0.000103	0.000693	CcSEcCtD
Carbachol—Rash—Gemcitabine—breast cancer	0.000102	0.000687	CcSEcCtD
Carbachol—Dermatitis—Gemcitabine—breast cancer	0.000102	0.000687	CcSEcCtD
Carbachol—Headache—Gemcitabine—breast cancer	0.000101	0.000683	CcSEcCtD
Carbachol—Flushing—Epirubicin—breast cancer	0.000101	0.000682	CcSEcCtD
Carbachol—Vomiting—Fluorouracil—breast cancer	0.000101	0.000681	CcSEcCtD
Carbachol—Dyspepsia—Docetaxel—breast cancer	0.000101	0.000681	CcSEcCtD
Carbachol—Rash—Fluorouracil—breast cancer	0.0001	0.000676	CcSEcCtD
Carbachol—Dermatitis—Fluorouracil—breast cancer	0.0001	0.000675	CcSEcCtD
Carbachol—Headache—Fluorouracil—breast cancer	9.96e-05	0.000671	CcSEcCtD
Carbachol—Nausea—Mitoxantrone—breast cancer	9.86e-05	0.000665	CcSEcCtD
Carbachol—Nausea—Irinotecan—breast cancer	9.86e-05	0.000665	CcSEcCtD
Carbachol—Pain—Docetaxel—breast cancer	9.81e-05	0.000661	CcSEcCtD
Carbachol—Dyspepsia—Capecitabine—breast cancer	9.78e-05	0.000659	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—breast cancer	9.73e-05	0.000656	CcSEcCtD
Carbachol—Nausea—Gemcitabine—breast cancer	9.6e-05	0.000647	CcSEcCtD
Carbachol—Pain—Capecitabine—breast cancer	9.5e-05	0.00064	CcSEcCtD
Carbachol—Nausea—Fluorouracil—breast cancer	9.44e-05	0.000637	CcSEcCtD
Carbachol—Flushing—Doxorubicin—breast cancer	9.35e-05	0.000631	CcSEcCtD
Carbachol—Flatulence—Epirubicin—breast cancer	9.34e-05	0.00063	CcSEcCtD
Carbachol—Diarrhoea—Paclitaxel—breast cancer	9.26e-05	0.000624	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—breast cancer	9.11e-05	0.000615	CcSEcCtD
Carbachol—Body temperature increased—Docetaxel—breast cancer	9.07e-05	0.000611	CcSEcCtD
Carbachol—Abdominal pain—Docetaxel—breast cancer	9.07e-05	0.000611	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—breast cancer	9e-05	0.000607	CcSEcCtD
Carbachol—Dizziness—Paclitaxel—breast cancer	8.95e-05	0.000603	CcSEcCtD
Carbachol—Body temperature increased—Capecitabine—breast cancer	8.78e-05	0.000592	CcSEcCtD
Carbachol—Abdominal pain—Capecitabine—breast cancer	8.78e-05	0.000592	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—breast cancer	8.64e-05	0.000583	CcSEcCtD
Carbachol—Vomiting—Paclitaxel—breast cancer	8.6e-05	0.00058	CcSEcCtD
Carbachol—Rash—Paclitaxel—breast cancer	8.53e-05	0.000575	CcSEcCtD
Carbachol—Dermatitis—Paclitaxel—breast cancer	8.52e-05	0.000575	CcSEcCtD
Carbachol—Syncope—Epirubicin—breast cancer	8.5e-05	0.000573	CcSEcCtD
Carbachol—Headache—Paclitaxel—breast cancer	8.48e-05	0.000572	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—breast cancer	8.43e-05	0.000569	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—breast cancer	8.33e-05	0.000562	CcSEcCtD
Carbachol—Infection—Methotrexate—breast cancer	8.21e-05	0.000554	CcSEcCtD
Carbachol—Nausea—Paclitaxel—breast cancer	8.04e-05	0.000542	CcSEcCtD
Carbachol—Hyperhidrosis—Methotrexate—breast cancer	7.99e-05	0.000539	CcSEcCtD
Carbachol—Syncope—Doxorubicin—breast cancer	7.87e-05	0.00053	CcSEcCtD
Carbachol—Diarrhoea—Docetaxel—breast cancer	7.85e-05	0.000529	CcSEcCtD
Carbachol—Hypotension—Methotrexate—breast cancer	7.72e-05	0.000521	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—breast cancer	7.71e-05	0.00052	CcSEcCtD
Carbachol—Infection—Epirubicin—breast cancer	7.69e-05	0.000518	CcSEcCtD
Carbachol—Shock—Epirubicin—breast cancer	7.61e-05	0.000513	CcSEcCtD
Carbachol—Diarrhoea—Capecitabine—breast cancer	7.6e-05	0.000512	CcSEcCtD
Carbachol—Dizziness—Docetaxel—breast cancer	7.58e-05	0.000511	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—breast cancer	7.48e-05	0.000504	CcSEcCtD
Carbachol—Dizziness—Capecitabine—breast cancer	7.34e-05	0.000495	CcSEcCtD
Carbachol—Vomiting—Docetaxel—breast cancer	7.29e-05	0.000492	CcSEcCtD
Carbachol—Dyspepsia—Methotrexate—breast cancer	7.28e-05	0.000491	CcSEcCtD
Carbachol—Rash—Docetaxel—breast cancer	7.23e-05	0.000488	CcSEcCtD
Carbachol—Hypotension—Epirubicin—breast cancer	7.23e-05	0.000487	CcSEcCtD
Carbachol—Dermatitis—Docetaxel—breast cancer	7.23e-05	0.000487	CcSEcCtD
Carbachol—Headache—Docetaxel—breast cancer	7.19e-05	0.000485	CcSEcCtD
Carbachol—Infection—Doxorubicin—breast cancer	7.11e-05	0.00048	CcSEcCtD
Carbachol—Pain—Methotrexate—breast cancer	7.07e-05	0.000477	CcSEcCtD
Carbachol—Vomiting—Capecitabine—breast cancer	7.06e-05	0.000476	CcSEcCtD
Carbachol—Shock—Doxorubicin—breast cancer	7.04e-05	0.000475	CcSEcCtD
Carbachol—Rash—Capecitabine—breast cancer	7e-05	0.000472	CcSEcCtD
Carbachol—Dermatitis—Capecitabine—breast cancer	7e-05	0.000472	CcSEcCtD
Carbachol—Headache—Capecitabine—breast cancer	6.96e-05	0.000469	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—breast cancer	6.92e-05	0.000467	CcSEcCtD
Carbachol—Nausea—Docetaxel—breast cancer	6.81e-05	0.000459	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—breast cancer	6.81e-05	0.000459	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—breast cancer	6.69e-05	0.000451	CcSEcCtD
Carbachol—Pain—Epirubicin—breast cancer	6.62e-05	0.000446	CcSEcCtD
Carbachol—Nausea—Capecitabine—breast cancer	6.6e-05	0.000445	CcSEcCtD
Carbachol—Abdominal pain—Methotrexate—breast cancer	6.54e-05	0.000441	CcSEcCtD
Carbachol—Body temperature increased—Methotrexate—breast cancer	6.54e-05	0.000441	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—breast cancer	6.3e-05	0.000425	CcSEcCtD
Carbachol—Pain—Doxorubicin—breast cancer	6.12e-05	0.000413	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—breast cancer	6.12e-05	0.000412	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—breast cancer	6.12e-05	0.000412	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—breast cancer	5.66e-05	0.000382	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—breast cancer	5.66e-05	0.000382	CcSEcCtD
Carbachol—Diarrhoea—Methotrexate—breast cancer	5.66e-05	0.000381	CcSEcCtD
Carbachol—Dizziness—Methotrexate—breast cancer	5.47e-05	0.000369	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—breast cancer	5.29e-05	0.000357	CcSEcCtD
Carbachol—Vomiting—Methotrexate—breast cancer	5.26e-05	0.000354	CcSEcCtD
Carbachol—Rash—Methotrexate—breast cancer	5.21e-05	0.000351	CcSEcCtD
Carbachol—Dermatitis—Methotrexate—breast cancer	5.21e-05	0.000351	CcSEcCtD
Carbachol—Headache—Methotrexate—breast cancer	5.18e-05	0.000349	CcSEcCtD
Carbachol—Dizziness—Epirubicin—breast cancer	5.12e-05	0.000345	CcSEcCtD
Carbachol—Vomiting—Epirubicin—breast cancer	4.92e-05	0.000332	CcSEcCtD
Carbachol—Nausea—Methotrexate—breast cancer	4.91e-05	0.000331	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—breast cancer	4.9e-05	0.00033	CcSEcCtD
Carbachol—Rash—Epirubicin—breast cancer	4.88e-05	0.000329	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—breast cancer	4.87e-05	0.000329	CcSEcCtD
Carbachol—Headache—Epirubicin—breast cancer	4.85e-05	0.000327	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—breast cancer	4.73e-05	0.000319	CcSEcCtD
Carbachol—Nausea—Epirubicin—breast cancer	4.6e-05	0.00031	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—breast cancer	4.55e-05	0.000307	CcSEcCtD
Carbachol—Rash—Doxorubicin—breast cancer	4.51e-05	0.000304	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—breast cancer	4.51e-05	0.000304	CcSEcCtD
Carbachol—Headache—Doxorubicin—breast cancer	4.48e-05	0.000302	CcSEcCtD
Carbachol—Nausea—Doxorubicin—breast cancer	4.25e-05	0.000287	CcSEcCtD
Carbachol—CHRM1—GPCR downstream signaling—IL2—breast cancer	6.57e-06	8.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RAF1—breast cancer	6.57e-06	8.63e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—breast cancer	6.57e-06	8.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAV1—breast cancer	6.56e-06	8.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—H2AFX—breast cancer	6.56e-06	8.61e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—breast cancer	6.55e-06	8.61e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RAF1—breast cancer	6.54e-06	8.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRG1—breast cancer	6.54e-06	8.59e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—E2F1—breast cancer	6.53e-06	8.58e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RELA—breast cancer	6.52e-06	8.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—E2F1—breast cancer	6.51e-06	8.55e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	6.5e-06	8.54e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—H2AFX—breast cancer	6.49e-06	8.53e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—breast cancer	6.49e-06	8.52e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	6.48e-06	8.51e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ERBB2—breast cancer	6.48e-06	8.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—E2F1—breast cancer	6.45e-06	8.47e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	6.42e-06	8.43e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MTOR—breast cancer	6.39e-06	8.39e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CB—breast cancer	6.39e-06	8.39e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SPP1—breast cancer	6.27e-06	8.24e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SPP1—breast cancer	6.25e-06	8.21e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—breast cancer	6.25e-06	8.2e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—breast cancer	6.23e-06	8.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB3—breast cancer	6.21e-06	8.15e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGFR2—breast cancer	6.2e-06	8.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SPP1—breast cancer	6.19e-06	8.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB3—breast cancer	6.19e-06	8.12e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGFR2—breast cancer	6.18e-06	8.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—breast cancer	6.17e-06	8.1e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—breast cancer	6.14e-06	8.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB3—breast cancer	6.13e-06	8.05e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGFR2—breast cancer	6.12e-06	8.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—breast cancer	6.1e-06	8.01e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1B—breast cancer	6e-06	7.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—breast cancer	5.97e-06	7.85e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—breast cancer	5.97e-06	7.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—breast cancer	5.95e-06	7.82e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—breast cancer	5.95e-06	7.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—breast cancer	5.93e-06	7.79e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—breast cancer	5.89e-06	7.74e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—breast cancer	5.88e-06	7.72e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—breast cancer	5.87e-06	7.71e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—breast cancer	5.87e-06	7.71e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—breast cancer	5.84e-06	7.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGFR1—breast cancer	5.78e-06	7.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGFR1—breast cancer	5.76e-06	7.56e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—breast cancer	5.72e-06	7.51e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—breast cancer	5.71e-06	7.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGFR1—breast cancer	5.7e-06	7.49e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HIF1A—breast cancer	5.69e-06	7.47e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HIF1A—breast cancer	5.67e-06	7.45e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CTNNB1—breast cancer	5.67e-06	7.44e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HIF1A—breast cancer	5.62e-06	7.37e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—breast cancer	5.55e-06	7.29e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LEP—breast cancer	5.55e-06	7.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LEP—breast cancer	5.54e-06	7.27e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1A—breast cancer	5.53e-06	7.27e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—breast cancer	5.52e-06	7.25e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CAV1—breast cancer	5.5e-06	7.23e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CAV1—breast cancer	5.48e-06	7.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LEP—breast cancer	5.48e-06	7.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KDR—breast cancer	5.44e-06	7.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CAV1—breast cancer	5.43e-06	7.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KDR—breast cancer	5.42e-06	7.12e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK8—breast cancer	5.4e-06	7.09e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—breast cancer	5.39e-06	7.07e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KDR—breast cancer	5.37e-06	7.05e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—breast cancer	5.3e-06	6.96e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—breast cancer	5.29e-06	6.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CD—breast cancer	5.25e-06	6.9e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FN1—breast cancer	5.24e-06	6.88e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—breast cancer	5.23e-06	6.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FN1—breast cancer	5.22e-06	6.86e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—breast cancer	5.19e-06	6.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NFKBIA—breast cancer	5.17e-06	6.8e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FN1—breast cancer	5.17e-06	6.79e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NFKBIA—breast cancer	5.16e-06	6.77e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOTCH1—breast cancer	5.13e-06	6.73e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—breast cancer	5.12e-06	6.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOTCH1—breast cancer	5.11e-06	6.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NFKBIA—breast cancer	5.11e-06	6.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOTCH1—breast cancer	5.06e-06	6.64e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—breast cancer	5.01e-06	6.58e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APC—breast cancer	5.01e-06	6.58e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KIT—breast cancer	5.01e-06	6.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APC—breast cancer	5e-06	6.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—breast cancer	5e-06	6.56e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KIT—breast cancer	5e-06	6.56e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—breast cancer	4.99e-06	6.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NOS3—breast cancer	4.96e-06	6.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGF—breast cancer	4.95e-06	6.51e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KIT—breast cancer	4.95e-06	6.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—breast cancer	4.95e-06	6.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APC—breast cancer	4.95e-06	6.5e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—breast cancer	4.94e-06	6.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGF—breast cancer	4.94e-06	6.48e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGF—breast cancer	4.89e-06	6.42e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK3—breast cancer	4.8e-06	6.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK3—breast cancer	4.78e-06	6.28e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK3—breast cancer	4.74e-06	6.22e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK3—breast cancer	4.72e-06	6.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BRAF—breast cancer	4.71e-06	6.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BRAF—breast cancer	4.7e-06	6.17e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CA—breast cancer	4.66e-06	6.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BRAF—breast cancer	4.65e-06	6.11e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1—breast cancer	4.59e-06	6.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—breast cancer	4.59e-06	6.03e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT2—breast cancer	4.59e-06	6.02e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CB—breast cancer	4.58e-06	6.01e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—breast cancer	4.58e-06	6.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1—breast cancer	4.57e-06	6.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT2—breast cancer	4.57e-06	6e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—breast cancer	4.57e-06	6e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—breast cancer	4.55e-06	5.98e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—breast cancer	4.54e-06	5.96e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1—breast cancer	4.53e-06	5.95e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT2—breast cancer	4.53e-06	5.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—breast cancer	4.51e-06	5.92e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—breast cancer	4.49e-06	5.89e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.41e-06	5.79e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CD—breast cancer	4.39e-06	5.77e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	4.36e-06	5.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SERPINE1—breast cancer	4.36e-06	5.72e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	4.35e-06	5.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CD—breast cancer	4.35e-06	5.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SERPINE1—breast cancer	4.34e-06	5.7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—breast cancer	4.31e-06	5.66e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	4.31e-06	5.66e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SERPINE1—breast cancer	4.3e-06	5.65e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—breast cancer	4.3e-06	5.65e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—breast cancer	4.26e-06	5.59e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—breast cancer	4.24e-06	5.57e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOS3—breast cancer	4.16e-06	5.46e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOS3—breast cancer	4.15e-06	5.45e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOS3—breast cancer	4.11e-06	5.39e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	3.96e-06	5.2e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—breast cancer	3.96e-06	5.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	3.95e-06	5.19e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—breast cancer	3.95e-06	5.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—breast cancer	3.93e-06	5.17e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RAF1—breast cancer	3.93e-06	5.17e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RAF1—breast cancer	3.92e-06	5.15e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RELA—breast cancer	3.92e-06	5.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	3.91e-06	5.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RELA—breast cancer	3.9e-06	5.13e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—breast cancer	3.9e-06	5.12e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CA—breast cancer	3.9e-06	5.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB2—breast cancer	3.89e-06	5.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RAF1—breast cancer	3.88e-06	5.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB2—breast cancer	3.88e-06	5.09e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RELA—breast cancer	3.87e-06	5.08e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB2—breast cancer	3.84e-06	5.04e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CB—breast cancer	3.84e-06	5.04e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MTOR—breast cancer	3.84e-06	5.04e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MTOR—breast cancer	3.83e-06	5.03e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CB—breast cancer	3.83e-06	5.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—breast cancer	3.81e-06	5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CB—breast cancer	3.79e-06	4.98e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MTOR—breast cancer	3.79e-06	4.98e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—breast cancer	3.77e-06	4.95e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL8—breast cancer	3.69e-06	4.85e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—breast cancer	3.68e-06	4.83e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—breast cancer	3.67e-06	4.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—breast cancer	3.65e-06	4.8e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—breast cancer	3.64e-06	4.78e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—breast cancer	3.62e-06	4.75e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—breast cancer	3.6e-06	4.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.6e-06	4.73e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1B—breast cancer	3.59e-06	4.72e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.57e-06	4.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.56e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—breast cancer	3.55e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—breast cancer	3.53e-06	4.64e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—breast cancer	3.53e-06	4.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—breast cancer	3.52e-06	4.62e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.52e-06	4.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—breast cancer	3.52e-06	4.62e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—breast cancer	3.51e-06	4.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—breast cancer	3.5e-06	4.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—breast cancer	3.49e-06	4.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—breast cancer	3.48e-06	4.57e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—breast cancer	3.46e-06	4.55e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—breast cancer	3.45e-06	4.53e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—breast cancer	3.44e-06	4.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—breast cancer	3.43e-06	4.51e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—breast cancer	3.43e-06	4.5e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—breast cancer	3.42e-06	4.49e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.4e-06	4.47e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CTNNB1—breast cancer	3.39e-06	4.46e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—breast cancer	3.39e-06	4.46e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—breast cancer	3.39e-06	4.45e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.36e-06	4.41e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—breast cancer	3.34e-06	4.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—breast cancer	3.33e-06	4.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.33e-06	4.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—breast cancer	3.32e-06	4.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1A—breast cancer	3.32e-06	4.35e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—breast cancer	3.31e-06	4.34e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—breast cancer	3.3e-06	4.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3.28e-06	4.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—breast cancer	3.28e-06	4.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK8—breast cancer	3.25e-06	4.26e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—breast cancer	3.24e-06	4.25e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK8—breast cancer	3.24e-06	4.25e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—breast cancer	3.23e-06	4.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK8—breast cancer	3.2e-06	4.21e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—breast cancer	3.2e-06	4.2e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—breast cancer	3.18e-06	4.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—breast cancer	3.08e-06	4.04e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—breast cancer	3.07e-06	4.03e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—breast cancer	3.04e-06	3.99e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—breast cancer	3e-06	3.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—breast cancer	2.99e-06	3.92e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—breast cancer	2.97e-06	3.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.96e-06	3.89e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—breast cancer	2.96e-06	3.88e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—breast cancer	2.93e-06	3.85e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.84e-06	3.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK3—breast cancer	2.83e-06	3.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.8e-06	3.68e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CA—breast cancer	2.79e-06	3.66e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—breast cancer	2.76e-06	3.62e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.75e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—breast cancer	2.75e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—breast cancer	2.74e-06	3.6e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—breast cancer	2.72e-06	3.57e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.72e-06	3.57e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—breast cancer	2.7e-06	3.54e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—breast cancer	2.69e-06	3.53e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—breast cancer	2.66e-06	3.5e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—breast cancer	2.55e-06	3.35e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—breast cancer	2.54e-06	3.34e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—breast cancer	2.52e-06	3.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.34e-06	3.07e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CA—breast cancer	2.33e-06	3.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.31e-06	3.03e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—breast cancer	2.28e-06	2.99e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—breast cancer	2.26e-06	2.97e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—breast cancer	2.26e-06	2.96e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—breast cancer	2.24e-06	2.94e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—breast cancer	2.17e-06	2.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—breast cancer	2.16e-06	2.84e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—breast cancer	2.14e-06	2.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—breast cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—breast cancer	2.07e-06	2.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—breast cancer	2.05e-06	2.69e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—breast cancer	1.91e-06	2.51e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—breast cancer	1.91e-06	2.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—breast cancer	1.89e-06	2.48e-05	CbGpPWpGaD
